This Press Release does notconstitute any offer, invitation, or solicitation to purchase securities."Forward-looking statements," as defined in the Private Securities LitigationReform Act of 1995, may be included in this press release. Moss and Backstreet Boys.JIVELabel Group is a unit of Sony Music Entertainment.About CKX, Inc.CKX, Inc. Kelly, Usher, Tool, Ciara, Chris Brown, P!nk, Britney Spears, OutKast, KirkFranklin, Three Days Grace, 311, Nick Lachey, T-Pain, Bullet For My Valentine,Buddy Guy, Living Things, Anthony Hamilton, Donnie McClurkin, John P Kee,Fred Hammond, Hezekiah Walker, Marvin Sapp, J. with her fellow Season 8finalists on the American Idols Live! Tour 2009.About 19 ENTERTAINMENT LTDSimon Fuller's 19 Entertainment Ltd.
The now 17 year old was born inCalifornia to Salvadorian immigrants, and has been "singing since she was atoddler" according to her family.This summer Allison will tour across the U.S. "Her bluesy, powerful voice, spunky attitude,and edgy star power immediately captivated us and it didn't matter where sheranked on Idol, we knew we wanted her to join our amazing crop of young talentat Jive." Allison Iraheta is from Downey, California. We all watched Allison grow in confidence and stature as sheperformed each week on the show and we can only imagine how far this specialgirl can continue to blossom in the years ahead.""Allison was an absolute stand-out this season," stated RCA/JIVE Label Group'sChairman and CEO Barry Weiss. She iswithout a doubt one of the best teenage singers 'American Idol' has everdiscovered. Early in the seasonAllison Iraheta caught the attention of Idol judges, with Kara DioGuardicommenting, "keep your eye on that girl!" One of her defining moments on theshow was her performance of the heart-wrenching Bonnie Raitt classic "I Can'tMake You Love Me" in the Top 8 round of performances."I think I'm still in shock that this is happening -- getting to record myfirst album and this whole awesome experience is a dream come true!"Simon Fuller, Creator and Executive Producer of American Idol and Founder &CEO of 19 Entertainment says, "Allison is an incredible young singer. She had aspired to be onAmerican Idol since its debut in 2002 when she was only 9. American Idol Finalist Allison Iraheta Signs to 19 Recordings; Debut Album tobe Released Fall 2009 on 19 Recordings/Jive RecordsNEW YORK, June 10 /PRNewswire/ -- It was announced today that 19 Recordingshas signed Allison Iraheta, and her recordings have been licensed to JiveRecords.(Photo: http:// )Allison made it to the Top 4 of the recently completed Season 8 of the FOX TVsensation American Idol.The vibrantly red-haired rocker was the youngestcontestant ever (age 16) to make it into the Top 12.
406, . 265, ; Media Relations: Paul Burroughs,Director of Communications, (418) 652-8525 ext. We disclaim any obligation to update any suchfactors or to publicly announce the result of any revisions to any of theforward-looking statements contained herein to reflect future results, eventsor developments except if we are requested by a governmental authority orapplicable law.(1) Reference: Verhamme KMC et al, Eur Urol 2003;44:539 and Nichol MB et al, J Urol 2009;181:2214.SOURCEAETERNA ZENTARIS INC.Investor Relations: Ginette Vallieres, Investor Relations Coordinator, (418)652-8525 ext. The Company does not undertake to update theseforward-looking statements. Investors are cautioned not to rely on theseforward-looking statements.
securities commissions foradditional information on risks and uncertainties relating to theforward-looking statements. Investors should consult the Company's quarterly andannual filings with the Canadian and U.S. Such risks and uncertainties include, amongothers, the availability of funds and resources to pursue R&D projects, thesuccessful and timely completion of clinical studies, the ability of theCompany to take advantage of business opportunities in the pharmaceuticalindustry, uncertainties related to the regulatory process and general changesin economic conditions. Securities Litigation Reform Act of 1995.Forward-looking statements involve known and unknown risks and uncertainties,which could cause the Company's actual results to differ materially from thosein the forward-looking statements. News releases and additional informationare available at StatementsThis press release contains forward-looking statements made pursuant to thesafe harbor provisions of the U.S.
is a global biopharmaceutical company focused onendocrine therapy and oncology, with proven expertise in drug discovery,development and commercialization. Currently available therapies may improve symptomsto some degree, but often come with sexual and other side effects.About AEterna Zentaris Inc.AEterna Zentaris Inc. While previous research on BPH etiology tendedto focus on testosterone and other hormones, more recent research suggestsother factors - including inflammation, various growth factors, andadrenoreceptors - actually may play a greater role in the development of BPHand LUTS.BPH is associated with LUTS, including: frequent urination, a sudden,uncontrollable urge to urinate, waking at night to urinate (nocturia),difficulty starting a urine stream (hesitancy and straining), decreasedstrength of the urine stream (weak flow), feeling that the bladder is notcompletely empty, an urge to urinate again soon after urinating and painduring urination (dysuria). Data from ongoing researchsuggest BPH and lower urinary tract symptoms (LUTS) are more complexconditions than once thought. It was launched on the market through Serono(now Merck Serono) in the U.S., Europe and in several other countries, as wellas in Japan through Shionogi.About Benign Prostatic HyperplasiaBenign prostatic hyperplasia (BPH) is one of the most common diseases of agingmen - affecting more than 20 million men in the United States - but itsetiology is far from being completely understood.
